Anebulo Pharmaceuticals Inc (ANEB)

Finanzdaten der Anebulo Pharmaceuticals Inc-Aktie (ANEB)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	39.71% 1.6643	2.7605	2.5437	2.4944	2.864
Operating Income/Loss	39.71% -1.6643	-2.7605	-2.5437	-2.4944	-2.864
Nonoperating Income/Loss	75.15% 0.0107	0.0431	0.0629	-	-
Income/Loss From Continuing Operations Before Tax	39.15% -1.6535	-2.7174	-2.4808	-2.4956	-2.798
Income/Loss From Continuing Operations After Tax	39.15% -1.6535	-2.7174	-2.4808	-2.4956	-2.798
Net Income/Loss	39.15% -1.6535	-2.7174	-2.4808	-2.4956	-2.798
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.56% 25.93	25.79	25.63	0.1856	25.63
Diluted Average Shares	0.56% 25.93	25.79	25.63	-	-
Basic Earnings Per Share	45.45% -0.06	-0.11	-0.10	0.84	-0.11
Diluted Earnings Per Share	45.45% -0.06	-0.11	-0.10	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-